Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease

A Randomized Trial of Oral and Transdermal Rivastigmine for Postural Instability in Parkinson Disease Dementia

(2018) Jaime McDonald et al.   CLINICAL NEUROPHARMACOLOGY

Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease

(2018) Angelo Antonini et al.   JOURNAL OF NEURAL TRANSMISSION

Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson’s disease and their caregivers

(2018) Rosella Ciurleo et al.   JOURNAL OF NEUROLOGY

Clinical aspects of adherence to pharmacotherapy in Parkinson disease

(2018) Igor Straka et al.   MEDICINE

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

(2018) Regina Katzenschlager et al.   LANCET NEUROLOGY

Intrajejunal levodopa infusion therapy for Parkinson’s disease: practical and pragmatic tips for successful maintenance of therapy

(2017) Nataliya Titova et al.   Expert Review of Neurotherapeutics

Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson’s disease: An open-label study

(2017) Annamária Juhász et al.   PARKINSONISM & RELATED DISORDERS

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

(2017) Angelo Antonini et al.   PARKINSONISM & RELATED DISORDERS

Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms

(2017) Jesse Mu et al.   Frontiers in Aging Neuroscience

Intrajejunal levodopa infusion therapy for Parkinson’s disease: practical and pragmatic tips for successful maintenance of therapy

(2017) Nataliya Titova et al.   Expert Review of Neurotherapeutics

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)

(2017) Rajesh Pahwa et al.   JAMA Neurology

Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy

(2017) Sebastian Loens et al.   Brain and Behavior

The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease

(2017) Julia Lowin et al.   JOURNAL OF MEDICAL ECONOMICS

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial

(2016) Emily J Henderson et al.   LANCET NEUROLOGY

Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

(2016) Marina Senek et al.   MOVEMENT DISORDERS

Apomorphine therapy in Parkinson's disease and future directions

(2016) Nataliya Titova et al.   PARKINSONISM & RELATED DISORDERS

Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson’s disease and its evolution study

(2016) Aiping Wang et al.   SAUDI PHARMACEUTICAL JOURNAL

Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment

(2015) A. Merola et al.   EUROPEAN JOURNAL OF NEUROLOGY

A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain

(2015) Olivier Rascol et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease

(2015) Leo Verhagen Metman et al.   MOVEMENT DISORDERS

Medication Adherence in Patients with Parkinson’s Disease

(2014) Naveed Malek et al.   CNS DRUGS

EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

(2014) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

(2013) C Warren Olanow et al.   LANCET NEUROLOGY

Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit

(2013) Karen L. Eskow Jaunarajs et al.   MOVEMENT DISORDERS

Rotigotine and specific non-motor symptoms of Parkinson's disease: Post hoc analysis of RECOVER

(2013) K. Ray Chaudhuri et al.   PARKINSONISM & RELATED DISORDERS

Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery

(2013) Thomas Müller et al.   PARKINSONISM & RELATED DISORDERS

Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies

(2012) Jan-Peer Elshoff et al.   CLINICAL THERAPEUTICS

Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease

(2012) Raffaella Di Giacopo et al.   MOVEMENT DISORDERS

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)

(2010) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

Adherence to antiparkinson medication in a multicenter European study

(2009) Donald Grosset et al.   MOVEMENT DISORDERS

Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets

(2008) K.A. Stockwell et al.   EXPERIMENTAL NEUROLOGY

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

(2008) Pedro J. García Ruiz et al.   MOVEMENT DISORDERS